Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein

Conclusions: This study provides a rapid design pipeline for a CRISPR-Cas13a-based antiviral tool against SARS-CoV-2. Moreover, it offers a novel approach for anti-virus study even if the precise structures of viral proteins are indeterminate.

Source: Theranostics - January 15, 2021 Category: Molecular Biology Authors: Lin Wang, Junhu Zhou, Qixue Wang, Yunfei Wang, Chunsheng Kang Tags: Research Paper Source Type: research